Health and Life Sciences
Displaying Results: [2341 - 2350] of 2384
| Title | Posted | Category |
|---|---|---|
|
Weston Brain Institute: Rapid Response - Canada 2019 (Parkinson's and Related Diseases) Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The Rapid... |
4 years 4 weeks ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Rapid Response - Canada 2020 (Alzheimer's and related diseases) Neurodegenerative diseases of aging are among the least understood and most under treated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. ... |
2 years 12 months ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Rapid Response - Canada 2020 (Parkinson's and related diseases) Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. ... |
2 years 12 months ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Rapid Response: Canada 2018 (Alzheimer’s and Related Diseases) Seed funding for novel, high-risk, high-reward translational research on neurodegenerative diseases of aging |
5 years 4 weeks ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Rapid Response: Canada 2019 (Parkinson's & Related Diseases) Seed Funding for novel, high-risk, high-reward translational research on neurodegenerative diseases of aging. Preliminary data is not required. New for 2018/19:
|
4 years 10 months ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Transformational Research - Canada 2020 (Alzheimer's and related diseases) Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ... |
2 years 12 months ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Transformational Research - Canada 2020 (Parkinson's and related diseases) Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ... |
2 years 12 months ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Transformational Research: Canada 2019 (Alzheimer’s & Related Diseases) Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ... |
4 years 4 weeks ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute: Transformational Research: Canada 2019 (Parkinson's & Related Diseases) Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. If ignored, the social and economic costs of managing these diseases will continue to rise. Meeting these challenges requires pioneering approaches to accelerating treatments. The ... |
4 years 4 weeks ago | Funding Opportunities and Sponsor News |
|
Weston Brain Institute:Early Phase Clinical Trials: Canada The Early Phase Clinical Trials program provides funding to support translational research that accelerates the development of therapeutics for neurodegenerative disease aging. |
5 years 4 weeks ago | Funding Opportunities and Sponsor News |